Dalton, James T.,Dodson, Shontelle,Steiner, Mitchell S.
申请号：
AU2012239901
公开号：
AU2012239901A1
申请日:
2012.04.09
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC)； treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient)； treating and preventing loss of physical function due to cancer or cancer therapy； increase of physical function； and increasing survival in a patient with NSCLC.
